Literature DB >> 10851255

Delineation of a complex karyotypic rearrangement by microdissection and CGH in a family affected with split foot.

J Weimer1, M Kiechle, U Wiedemann, H Tönnies, H Neitzel, E Ruhenstroth, A Ovens-Raeder, N Arnold.   

Abstract

We report on a male patient and members of his family with additional material in chromosome 3. This derivative chromosome 3 was transmitted from his mother who had a complex rearrangement between chromosomes 2, 3, and 7. It was possible to delineate her chromosomal rearrangement by microdissection and reverse painting and to exclude these aberrations from being responsible for neonatal deaths and several abortions in this family. Two members of this family suffer from ectrodactyly or split hand/foot malformations (SHFM) of the feet which possibly correlates with the derivative chromosome 7 containing a breakpoint in the SHFM1 critical region involving several homeobox genes.

Entities:  

Mesh:

Year:  2000        PMID: 10851255      PMCID: PMC1734612          DOI: 10.1136/jmg.37.6.442

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  2 in total

1.  Split hand/foot malformation due to chromosome 7q aberrations(SHFM1): additional support for functional haploinsufficiency as the causative mechanism.

Authors:  Anneke T van Silfhout; Peter C van den Akker; Trijnie Dijkhuizen; Joke B G M Verheij; Maran J W Olderode-Berends; Klaas Kok; Birgit Sikkema-Raddatz; Conny M A van Ravenswaaij-Arts
Journal:  Eur J Hum Genet       Date:  2009-04-29       Impact factor: 4.246

Review 2.  A multiple translocation event in a patient with hexadactyly, facial dysmorphism, mental retardation and behaviour disorder characterised comprehensively by molecular cytogenetics. Case report and review of the literature.

Authors:  Jörg Seidel; Anita Heller; Gabriele Senger; Heike Starke; Ilse Chudoba; Christina Kelbova; Holger Tönnies; Heidemarie Neitzel; Claudia Haase; Volkmar Beensen; Felix Zintl; Uwe Claussen; Thomas Liehr
Journal:  Eur J Pediatr       Date:  2003-06-19       Impact factor: 3.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.